Says Steven Abramson, an FDA adviser and chief of rheumatology at New York University's Hospital for Joint Diseases: "This is the most exciting time I've witnessed.
Oral Apremilast Achieves Statistical Significance for Primary and Secondary Endpoints in a Phase II Trial in Patients ... BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented results from a randomized, placebo-controlled phase II trial in patients with Behçet’s disease (BD) at EULAR, the European Congress of Rheumatology annual meeting in Madrid. The Company announced statistical significance for the primary endpoint of the mean number ...
June 14, 2013 - Business Wire
EULAR honors outstanding contributions to rheumatology ( European League Against Rheumatism ) EULAR today announced the recipients of the 13th annual Meritorious Service Award at the opening of the European League Against Rheumatism Annual Congress. The award recognizes a lifetime of achievement for Professors Barry Bresnihan, Ireland, and Jean-Michel Dayer, Switzerland, for their services to rheumatology, and was bestowed upon Professor Bresnihan ...
June 12, 2013 - EurekAlert!
John Swinney in Aberdeen Press and Journal This agreement further strengthens Aetna's robust metro-New York network, adding the world's leading hospital for orthopedics and rheumatology and a growing number of orthopedic surgeons and rheumatologists who practice at HSS, as well as HSS... Glenn http://www.google.com/url?q=http://en.wikipedia.org/wiki/Glenn&source=dictionary&usg=AFQjCNErmrlxQnvsKxMArOnLMjD1-fuoRg Business Wire (press release) http://www.google.com/url?q=http://www.businesswire.com/news/google/20080707005641/en&source=dictionary&usg=AFQjCNFw8tLZaF7WlsBCRlinkW_QPWDN_Q Jul 7, 2008
83833 111287 rheumatology Mr Swinney said: The health board has confirmed that no final decisions on the rheumatology service have been made, and it has assured the deputy first minister that the views of patients and local people will be taken fully into account in any...